According to Tedros Adhanom Ghebreyesus, director-general of the World Health Organization (WHO), about 7,500 cases of monkeypox were reported last week, a 20% rise from the previous 35,000 instances reported from 92 countries and territories.
According to Ghebreyesus, a total of 12 people have died as a result of monkeypox worldwide to date. The outbreak of monkeypox may be controlled in part by vaccines, according to a top WHO official, and affected communities in many countries have a high demand for vaccines.
As instances of monkeypox continue to climb around the globe, Bavarian Nordic A/S, the only company with a licensed vaccine for the disease, stated it is no longer assured it can satisfy demand. Ghebreyesus made his comments at the same time.
To keep up with the growing demand, the Danish company is now looking into outsourcing some of the production, along with the technology transfer to a US contract manufacturer.
Rolf Sass Sorensen, a vice president of the company, said over the phone on Wednesday that “it’s a highly dynamic market position.” Even with the upgrading of our current manufacturing facility in Denmark, demand keeps increasing, and it is no longer assured that we can continue to meet it.